Karen A. Graham

1.0k total citations
18 papers, 816 citations indexed

About

Karen A. Graham is a scholar working on Psychiatry and Mental health, Physiology and Social Psychology. According to data from OpenAlex, Karen A. Graham has authored 18 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Physiology and 3 papers in Social Psychology. Recurrent topics in Karen A. Graham's work include Schizophrenia research and treatment (10 papers), Diet and metabolism studies (5 papers) and Mental Health and Psychiatry (3 papers). Karen A. Graham is often cited by papers focused on Schizophrenia research and treatment (10 papers), Diet and metabolism studies (5 papers) and Mental Health and Psychiatry (3 papers). Karen A. Graham collaborates with scholars based in United States, United Kingdom and Norway. Karen A. Graham's co-authors include Diana O. Perkins, Joyce B. Harp, Jeffrey A. Lieberman, David L. Penn, Amy E. Pinkham, L. Fredrik Jarskog, J.A. Lieberman, Jane Leserman, Lloyd J. Edwards and Robert Barrier and has published in prestigious journals such as American Journal of Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Karen A. Graham

16 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen A. Graham United States 12 556 167 146 140 109 18 816
Evangelos Papanastasiou United Kingdom 8 564 1.0× 155 0.9× 142 1.0× 104 0.7× 131 1.2× 11 826
Nikolaj Bak Denmark 15 499 0.9× 88 0.5× 61 0.4× 102 0.7× 384 3.5× 30 865
Yia‐Ping Liu Taiwan 18 309 0.6× 147 0.9× 76 0.5× 88 0.6× 166 1.5× 55 879
Craig Goodman Israel 15 265 0.5× 209 1.3× 68 0.5× 26 0.2× 177 1.6× 28 671
Max Lam United States 17 556 1.0× 125 0.7× 134 0.9× 59 0.4× 208 1.9× 46 894
Meihong Xiu China 18 509 0.9× 141 0.8× 32 0.2× 141 1.0× 256 2.3× 110 1.1k
Anna Walter Switzerland 18 304 0.5× 85 0.5× 30 0.2× 97 0.7× 364 3.3× 24 889
Zheng Lu China 16 441 0.8× 172 1.0× 99 0.7× 32 0.2× 135 1.2× 46 696
Alessandro Pigoni Italy 15 241 0.4× 108 0.6× 36 0.2× 23 0.2× 184 1.7× 44 617
Xiangyang Zhang China 16 231 0.4× 141 0.8× 30 0.2× 54 0.4× 131 1.2× 61 632

Countries citing papers authored by Karen A. Graham

Since Specialization
Citations

This map shows the geographic impact of Karen A. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen A. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen A. Graham more than expected).

Fields of papers citing papers by Karen A. Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen A. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen A. Graham. The network helps show where Karen A. Graham may publish in the future.

Co-authorship network of co-authors of Karen A. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Karen A. Graham. A scholar is included among the top collaborators of Karen A. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen A. Graham. Karen A. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Zhou, Wenli, Karen A. Graham, Baltasar Lucendo‐Villarin, et al.. (2018). Combining stem cell-derived hepatocytes with impedance sensing to better predict human drug toxicity. Expert Opinion on Drug Metabolism & Toxicology. 15(1). 77–83. 5 indexed citations
3.
Woods, Scott W., John R. Saksa, Michael T. Compton, et al.. (2017). 112. Effects of Ziprasidone Versus Placebo in Patients at Clinical High Risk for Psychosis. Schizophrenia Bulletin. 43(suppl_1). S58–S58. 20 indexed citations
4.
Graham, Karen A., Fatima H. Labeed, Mark P. Lewis, et al.. (2015). A dielectrophoretic method of discrimination between normal oral epithelium, and oral and oropharyngeal cancer in a clinical setting. The Analyst. 140(15). 5198–5204. 31 indexed citations
5.
Sheitman, Brian, Robert M. Hamer, Karen A. Graham, et al.. (2014). A Naturalistic Comparison of the Long-Term Metabolic Adverse Effects of Clozapine Versus Other Antipsychotics for Patients With Psychotic Illnesses. Journal of Clinical Psychopharmacology. 34(4). 441–445. 16 indexed citations
6.
Liang, Kristina Xiao, Karen A. Graham, A. C. Johannessen, Daniela Elena Costea, & Fatima H. Labeed. (2014). Human oral cancer cells with increasing tumorigenic abilities exhibit higher effective membrane capacitance. Integrative Biology. 6(5). 545–554. 37 indexed citations
7.
Graham, Karen A., et al.. (2014). Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first‐episode schizophrenia. Early Intervention in Psychiatry. 9(5). 397–405. 63 indexed citations
8.
Keefe, Richard S.E., Sophia Vinogradov, Alice Medalia, et al.. (2012). Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial. The Journal of Clinical Psychiatry. 73(7). 1016–1022. 64 indexed citations
9.
Penn, David L., et al.. (2012). Evaluation of a multi-element treatment center for early psychosis in the United States. Social Psychiatry and Psychiatric Epidemiology. 47(10). 1607–1615. 20 indexed citations
10.
Keefe, Richard S.E., Sophia Vinogradov, Alice Medalia, et al.. (2010). FEASIBILITY STUDY OF MULTI-SITE COGNITIVE REMEDIATION IN THE SCHIZOPHRENIA TRIALS NETWORK (CRSTN). Schizophrenia Research. 117(2-3). 394–394. 3 indexed citations
11.
Graham, Karen A., Hyunsoon Cho, Kimberly A. Brownley, & Joyce B. Harp. (2008). Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects. Schizophrenia Research. 101(1-3). 287–294. 48 indexed citations
12.
13.
Graham, Karen A., Hongbin Gu, Jeffrey A. Lieberman, Joyce B. Harp, & Diana O. Perkins. (2005). Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects Who Gained Weight With Olanzapine. American Journal of Psychiatry. 162(9). 1744–1746. 71 indexed citations
14.
Graham, Karen A. & Diana O. Perkins. (2005). Drs. Graham and Perkins Reply. American Journal of Psychiatry. 162(9). 1765–1765.
15.
16.
Graham, Karen A., Diana O. Perkins, Lloyd J. Edwards, et al.. (2004). Effect of Olanzapine on Body Composition and Energy Expenditure in Adults With First-Episode Psychosis. American Journal of Psychiatry. 162(1). 118–123. 120 indexed citations
17.
Graham, Karen A., Diana O. Perkins, Joyce B. Harp, et al.. (2003). Investigation of olanzapine-associated weight gain in first episode subjects. Schizophrenia Research. 60(1). 355–356. 1 indexed citations
18.
Perkins, Diana O., et al.. (2000). Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophrenia Research. 44(1). 1–10. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evangelos Papanastasiou Breakdown of academic impact, for papers by Nikolaj Bak Breakdown of academic impact, for papers by Yia‐Ping Liu Breakdown of academic impact, for papers by Craig Goodman Breakdown of academic impact, for papers by Max Lam Breakdown of academic impact, for papers by Meihong Xiu Breakdown of academic impact, for papers by Anna Walter Breakdown of academic impact, for papers by Zheng Lu Breakdown of academic impact, for papers by Alessandro Pigoni Breakdown of academic impact, for papers by Xiangyang Zhang
Rankless by CCL
2026